- Between laughs and 'disaster', Trump divides Davos
- Hundreds of people protest ahead of Swiss Davos meeting
- US falling behind on wind power, think tank warns
- US news giant CNN eyes 200 job cuts, streaming overhaul
- Rubio chooses Central America for first trip amid Panama Canal pressure
- Wall Street's AI-fuelled rally falters, oil slumps
- Trump tells Davos elites: produce in US or pay tariffs
- Progressive politics and nepo 'babies': five Oscar takeaways
- American Airlines shares fall on lackluster 2025 profit outlook
- France to introduce new sex education guidelines in schools
- Wall Street's AI-fuelled rally falters
- Drinking water in many French cities contaminated: study
- After Musk gesture, activists project 'Heil' on Tesla plant
- ICC prosecutor seeks arrest of Taliban leaders over persecution of women
- Syria's economy reborn after being freed from Assad
- Shoppers unaware as Roman tower lurks under French supermarket
- Stocks mainly rise after Wall Street's AI-fuelled rally
- Singer Chris Brown sues Warner Bros for $500 mn over documentary
- J-pop star Nakai to retire after sexual misconduct allegations
- Leaky, crowded and hot: Louvre boss slams her own museum
- WWF blasts Sweden, Finland over logging practices
- How things stand in China-US trade tensions with Trump 2.0
- Most Asian markets rise after Wall Street's AI-fuelled rally
- Fire-hit Hollywood awaits Oscar nominees, with 'Emilia Perez' in front
- New rider in town: Somalia's first woman equestrian turns heads
- Most Asian markets extend AI-fuelled rally
- Bangladesh student revolutionaries' dreams dented by joblessness
- Larry Ellison, tech's original maverick, makes Trump era return
- Political crisis hits South Korea growth: central bank
- Photonis Launches Two Market-Leading Solutions to Advance Single Photon Detection and Imaging Applications
- Les Paul owned by guitar god Jeff Beck auctioned for over £1 mn
- Musk bashes Trump-backed AI mega project
- Does China control the Panama Canal, as Trump claims?
- Yemen's Huthis say freed detained ship's crew after Gaza truce
- Mel B, Trump and Milei: What happened at Davos Wednesday
- Argentina's Milei says would leave Mercosur for US trade deal
- Fashion world 'afraid' of Trump, says Van Beirendonck
- P&G sees China improvement but consumers 'still struggling'
- Stock markets mostly higher as they track Trump plans, earnings
- Anti-Semitic acts at 'historic' highs in France despite 2024 fall: council
- Trump's meme coin venture sparks backlash
- Global green energy push likely to continue despite Trump climate retreat: UN
- Prince Harry settles lawsuit against Murdoch's UK tabloids
- Stock markets diverge tracking Trump plans
- Sudan 'political' banknote switch causes cash crunch
- Masa Son, Trump's Japanese buddy with the Midas Touch
- Borussia Dortmund sack coach Nuri Sahin after Champions League setback
- 'Love for humanity': Low-crime Japan's unpaid parole officers
- Brazil saw 79% jump in area burned by fires in 2024: monitor
- No home, no insurance: The double hit from Los Angeles fires
Sacklers, Purdue to pay $7.4 bn over opioid crisis
Several US states have reached a $7.4 billion settlement with the Sackler family and their pharmaceutical company Purdue over the opioid crisis that has ravaged the lives of millions of Americans, officials said Thursday.
The opioid crisis, which has caused more than 500,000 deaths over 20 years in the United States, has triggered a flurry of lawsuits against drugmakers, distributors and pharmacies from victims and the authorities.
Thursday's settlement, which will see funds routed to communities and individuals affected by opioids, is the largest of several targeting the makers and sellers of the highly addictive drugs.
The $7.4 billion settlement was agreed "in principle with members of the Sackler family and their company Purdue Pharma for their instrumental role in creating the opioid crisis," New York Attorney General Letitia James's office said in a statement.
"The settlement ends the Sacklers's control of Purdue and ability to sell opioids in the United States and will deliver funding directly to communities across the country over the next 15 years to support opioid addiction treatment, prevention, and recovery programs.
"The $7.4 billion settlement in principle (is) the nation's largest."
Purdue and other opioid makers and distributors were accused of encouraging free-wheeling prescription of their products through aggressive marketing tactics while hiding how addictive the drugs are.
- Litigation avalanche -
Facing an avalanche of litigation, in 2021 Purdue pled guilty to three criminal charges over its marketing of OxyContin.
The Sacklers have consistently denied wrongdoing over the opioid crisis.
The settlement featured some 15 states including New York, Florida and Pennsylvania.
"The Sackler family relentlessly pursued profit at the expense of vulnerable patients, and played a critical role in starting and fueling the opioid epidemic," James said in a statement.
"While no amount of money will ever fully repair the damage they caused, this massive influx of funds will bring resources to communities in need so that we can heal."
The settlement includes the eight heirs of the original Purdue founders Raymond and Mortimer Sackler who served on the company board -- Richard, Kathe, Mortimer Jr, Ilene, David, and Theresa Sackler.
For many people, opioid addiction begins with prescribed pain pills, before they increase their consumption and eventually turn to illicit drugs such as heroin and fentanyl, an extremely powerful synthetic opioid.
Opioid victims and their families addressed the Sackler family, owners of Purdue Pharma, the maker of OxyContin, directly in a US courtroom in March 2022 as part of the company's bankruptcy case.
"We buried Matthew and Kyle because of your family's vicious acts of disregard for human life," Liz Fitzgerald said of the deaths of two of her sons, who died at ages 32 and 25 after years of dealing with opioid addictions.
"Two boys are gone because of your 'safe' medication," Fitzgerald said.
M.Anderson--CPN